233 related articles for article (PubMed ID: 34661810)
1. Comparative expression analysis of tRF-3001a and tRF-1003 with corresponding miRNAs (miR-1260a and miR-4521) and their network analysis with breast cancer biomarkers.
Hussain SA; Deepak KV; Nanjappa DP; Sherigar V; Nandan N; Suresh PS; Venkatesh T
Mol Biol Rep; 2021 Nov; 48(11):7313-7324. PubMed ID: 34661810
[TBL] [Abstract][Full Text] [Related]
2. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
[TBL] [Abstract][Full Text] [Related]
3. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
5. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
7. tRFs: miRNAs in disguise.
Venkatesh T; Suresh PS; Tsutsumi R
Gene; 2016 Apr; 579(2):133-8. PubMed ID: 26743126
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
Bitaraf A; Babashah S; Garshasbi M
J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
[TBL] [Abstract][Full Text] [Related]
9. tRFTars: predicting the targets of tRNA-derived fragments.
Xiao Q; Gao P; Huang X; Chen X; Chen Q; Lv X; Fu Y; Song Y; Wang Z
J Transl Med; 2021 Feb; 19(1):88. PubMed ID: 33632236
[TBL] [Abstract][Full Text] [Related]
10. The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?
Kaba M; Pirinççi N; Demir M; Kaba S; Oztuzcu S; Verep S
Int Urol Nephrol; 2023 Oct; 55(10):2483-2491. PubMed ID: 37338656
[TBL] [Abstract][Full Text] [Related]
11. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
Ozawa PMM; Vieira E; Lemos DS; Souza ILM; Zanata SM; Pankievicz VC; Tuleski TR; Souza EM; Wowk PF; Urban CA; Kuroda F; Lima RS; Almeida RC; Gradia DF; Cavalli IJ; Cavalli LR; Malheiros D; Ribeiro EMSF
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963351
[TBL] [Abstract][Full Text] [Related]
12. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
13. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
14. Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study.
Holubekova V; Kolkova Z; Grendar M; Brany D; Dvorska D; Stastny I; Jagelkova M; Zelinova K; Samec M; Liskova A; Laucekova Z; Kudela E; Bobrovska M; Kalman M; Zubor P; Dankova Z
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023154
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer.
Yan LR; Wang A; Lv Z; Yuan Y; Xu Q
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439992
[TBL] [Abstract][Full Text] [Related]
16. tRF-19-W4PU732S promotes breast cancer cell malignant activity by targeting inhibition of RPL27A (ribosomal protein-L27A).
Zhang Z; Liu Z; Zhao W; Zhao X; Tao Y
Bioengineered; 2022 Feb; 13(2):2087-2098. PubMed ID: 35030975
[TBL] [Abstract][Full Text] [Related]
17. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
18. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.
Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S
J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314
[TBL] [Abstract][Full Text] [Related]
19. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
[TBL] [Abstract][Full Text] [Related]
20. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]